Literature DB >> 18314361

Current concepts on the use of antimicrobials in cats.

G A Albarellos1, M F Landoni.   

Abstract

This article reviews the general pharmacological properties of antimicrobial drugs used in feline medicine. It focuses on recent advances in pharmacokinetics, providing an update on indications, drug interactions and adverse reactions or toxicity in the cat. Attention is given to the most used groups, such as cephalosporins and fluoroquinolones, reviewing their basic features and clinical uses, and discusses the pharmacokinetic advantages of the newer members of each group. The older groups (penicillins, aminoglycosides, macrolides and tetracyclines) are also considered with regard to their general features and current uses, and any recent reports on adverse reactions in cats are provided.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314361     DOI: 10.1016/j.tvjl.2008.01.001

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  4 in total

1.  Effects of oral orbifloxacin on fecal coliforms in healthy cats: a pilot study.

Authors:  Kazuki Harada; Atsushi Sasaki; Takae Shimizu
Journal:  J Vet Med Sci       Date:  2015-08-27       Impact factor: 1.267

2.  Randomized, Controlled, Crossover trial of Prevention of Clindamycin-Induced Gastrointestinal Signs Using a Synbiotic in Healthy Research Cats.

Authors:  J E Stokes; J M Price; J C Whittemore
Journal:  J Vet Intern Med       Date:  2017-07-29       Impact factor: 3.333

Review 3.  Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.

Authors:  Francesca De Santis; Andrea Boari; Francesco Dondi; Paolo Emidio Crisi
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

4.  Short and long-term effects of a synbiotic on clinical signs, the fecal microbiome, and metabolomic profiles in healthy research cats receiving clindamycin: a randomized, controlled trial.

Authors:  Jacqueline C Whittemore; Jennifer E Stokes; Nicole L Laia; Joshua M Price; Jan S Suchodolski
Journal:  PeerJ       Date:  2018-07-17       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.